Niclosamide

This classification denotes an antihelminthic agent with the molecular formula C13H8Cl2N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KK8CQ2K8G, chemically known as 2′,5-dichloro-4′-nitrosalicylanilide but generally known as niclosamide, which bears US NIH Compound Identifier 4477. European Medicines Agency schedules Niclosamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09230MIG. The term NICLOSAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules niclosamide in its Anatomical Therapeutic Chemical (ATC) Classification. NICLOSAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule niclosamide under HS 29242995 and SITC 51479. As of Q4 2014, NICLOSAMIDE remains the US FDA Preferred Term for this commodity. Niclosamide bears US NLM identifiers UMLS ID C0028017 and NCI Concept Code C66240. SMILES: CLC1C(NC(=O)C2C(O)CCC(CL)C2)CCC([N](=O)O)C1.